{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:49:16Z","timestamp":1781189356528,"version":"3.54.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.ejphar.2005.09.028","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T12:48:02Z","timestamp":1131022082000},"page":"163-171","source":"Crossref","is-referenced-by-count":57,"title":["New achievements and pharmacotherapeutic approaches in the treatment of alcohol dependence"],"prefix":"10.1016","volume":"526","author":[{"given":"Falk","family":"Kiefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2005.09.028_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s002130000607","article-title":"Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence","volume":"154","author":"Ait-Daoud","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2005.09.028_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1530-0277.1995.tb01475.x","article-title":"The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behaviour","volume":"19","author":"Anton","year":"1995","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib4","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1176\/ajp.156.11.1758","article-title":"Naltrexone and cognitive behavioral therapy of outpatient alcoholics: results of a placebo-controlled trial","volume":"156","author":"Anton","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00004714-200102000-00013","article-title":"Posttreatment results of combining naltrexone and cognitive behavior therapy for the treatment of alcoholism","volume":"21","author":"Anton","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2005.09.028_bib5","first-page":"173","article-title":"Impairment in memory function and neurodegenerative changes in the cholinergic forebrain system induced by chronic intake of ethanol","volume":"44","author":"Arendt","year":"1994","journal-title":"Neural. Transm."},{"key":"10.1016\/j.ejphar.2005.09.028_bib6","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/01.ALC.0000075548.83053.A9","article-title":"A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence","volume":"27","author":"Balldin","year":"2003","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0006-8993(93)90309-B","article-title":"Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats","volume":"621","author":"Benjamin","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1530-0277.1998.tb04295.x","article-title":"Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study","volume":"22","author":"Besson","year":"1998","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/13543784.14.4.371","article-title":"Novel anticonvulsants in the treatment of alcoholism","volume":"14","author":"Book","year":"2005","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejphar.2005.09.028_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000284626","article-title":"Buspirone in the treatment of alcoholic patients","volume":"22","author":"Bruno","year":"1989","journal-title":"Psychopathology"},{"key":"10.1016\/j.ejphar.2005.09.028_bib11","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0022-3565(24)38200-X","article-title":"Effects of ethanol on recombinant human neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes","volume":"289","author":"Cardoso","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.09.028_bib12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/alcalc\/35.6.587","article-title":"A multicentre, randomised, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence in adults","volume":"35","author":"Chick","year":"2000","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.ejphar.2005.09.028_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/alcalc\/35.2.176","article-title":"United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol","volume":"35","author":"Chick","year":"2000","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.ejphar.2005.09.028_bib100","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/archpsyc.1997.01830200024004","article-title":"Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial","volume":"54","author":"Cornelius","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0011-393X(02)80096-0","article-title":"Long-term efficacy of sertraline in the prevention of alcoholic relapses in alcohol-dependent patients: a single-center, double-blind, randomized, placebo-controlled, parallel-group study","volume":"63","author":"Co\u015fkunol","year":"2002","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib15","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archpsyc.1997.01830240090013","article-title":"The safety profile of naltrexone in the treatment of alcoholism","volume":"54","author":"Croop","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib16","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1001\/jama.262.12.1646","article-title":"Lithium treatment of depressed and nondepressed alcoholics","volume":"262","author":"Dorus","year":"1989","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ejphar.2005.09.028_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF02916253","article-title":"OLITA: an alternative in the treatment of therapy-resistant chronic alcoholics. First evaluation of a new approach","volume":"247","author":"Ehrenreich","year":"1997","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2005.09.028_bib18","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/jama.256.11.1449","article-title":"Disulfiram treatment of alcoholism. A Veterans Administration Cooperative Study","volume":"256","author":"Fuller","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2005.09.028_bib19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1530-0277.1992.tb00658.x","article-title":"Gamma-hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study","volume":"16","author":"Gallimberti","year":"1992","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib21","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jama.281.14.1318","article-title":"Pharmacological treatment of alcohol dependence: a review of the evidence","volume":"281","author":"Garbutt","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2005.09.028_bib20","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.293.13.1617","article-title":"Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial","volume":"293","author":"Garbutt","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2005.09.028_bib22","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00004714-200212000-00009","article-title":"Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study","volume":"22","author":"Gastpar","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2005.09.028_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0006-8993(85)90381-6","article-title":"Low doses of ethanol activate dopaminergic neurons in the ventral tegemental area","volume":"348","author":"Gessa","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/oxfordjournals.alcalc.a045093","article-title":"Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour","volume":"26","author":"Gewiss","year":"1991","journal-title":"Alcohol Alcohol."},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2005.09.028_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/oxfordjournals.alcalc.a008216","article-title":"Implications of endogenous opioids and dopamine in alcoholism: human and basic science studies","volume":"31","author":"Gianoulakis","year":"1996","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.ejphar.2005.09.028_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0376-8716(98)00062-3","article-title":"The neurobiology of alcohol abuse and alcoholism: building knowledge, creating hope","volume":"51","author":"Gordis","year":"1998","journal-title":"Drug. Alcohol Depend."},{"key":"10.1016\/j.ejphar.2005.09.028_bib27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1530-0277.1992.tb01373.x","article-title":"Effects of fluoxetine on alcohol consumption in male alcoholics","volume":"16","author":"Gorelick","year":"1992","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s002130050685","article-title":"The role of GABAA receptors in the acute and chronic effects of ethanol","volume":"139","author":"Grobin","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2005.09.028_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00004714-200106000-00006","article-title":"Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial","volume":"21","author":"Hein\u00e4l\u00e4","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2005.09.028_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s002130050688","article-title":"Naltrexone treatment of comorbid alcohol and cocaine use disorders","volume":"139","author":"Hersh","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2005.09.028_bib32","first-page":"109","article-title":"Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholics","volume":"11","author":"Janiri","year":"1996","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2005.09.028_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s002130000371","article-title":"Neuropharmacological treatments for alcoholism: scientific basis and clinical findings","volume":"149","author":"Johnson","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2005.09.028_bib35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s002130050126","article-title":"Ritanserin in the treatment of alcohol dependence \u2014 a multi-center clinical trial. Ritanserin Study Group","volume":"128","author":"Johnson","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2005.09.028_bib36","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.284.8.963","article-title":"Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomised clinical trial","volume":"284","author":"Johnson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2005.09.028_bib33","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archpsyc.61.9.905","article-title":"Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial","volume":"61","author":"Johnson","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib37","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1530-0277.1996.tb01686.x","article-title":"A placebo-controlled, double-blind study of fluoxetine in severe alcohol-dependence: adjunctive pharmacotherapy during and after inpatient treatment","volume":"20","author":"Kabel","year":"1996","journal-title":"Alcohol., Clin. Exp. Res."},{"issue":"6","key":"10.1016\/j.ejphar.2005.09.028_bib40","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/alcalc\/agh093","article-title":"Combined therapy: what does acamprosate and naltrexone combination tell us?","volume":"36","author":"Kiefer","year":"2004","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.ejphar.2005.09.028_bib39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archpsyc.60.1.92","article-title":"Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study","volume":"60","author":"Kiefer","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0924-2708.2004.00093.x","article-title":"Long-term effects of pharmacotherapy on relapse prevention in alcohol dependence","volume":"16","author":"Kiefer","year":"2004","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.ejphar.2005.09.028_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1530-0277.1998.tb03611.x","article-title":"Neurocircuitry targets in ethanol reward and dependence","volume":"22","author":"Koob","year":"1998","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib42","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archpsyc.1994.03950090052008","article-title":"Buspirone treatment of anxious alcoholics: a placebo-controlled trial","volume":"51","author":"Kranzler","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib43","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1176\/ajp.152.3.391","article-title":"Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics","volume":"152","author":"Kranzler","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0893-133X(99)00135-9","article-title":"Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial","author":"Kranzler","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2005.09.028_bib46","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMoa011127","article-title":"Naltrexone in the treatment of alcohol dependence","volume":"345","author":"Krystal","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2005.09.028_bib48","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5694\/j.1326-5377.2002.tb04550.x","article-title":"Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting","volume":"176","author":"Latt","year":"2002","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.ejphar.2005.09.028_bib51","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1360-0443.1995.tb01088.x","article-title":"Acamprosate in alcohol dependence: how does it work?","volume":"90","author":"Littleton","year":"1995","journal-title":"Addiction"},{"key":"10.1016\/j.ejphar.2005.09.028_bib52","series-title":"Nalmefene in the Treatment of Heavy Drinkers. 4th ISAM Abstract, Trieste","author":"M\u00e4kel\u00e4","year":"2001"},{"key":"10.1016\/j.ejphar.2005.09.028_bib53","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1530-0277.1992.tb00691.x","article-title":"A placebo-controlled trial of buspirone in anxious inpatient alcoholics","volume":"16","author":"Malcolm","year":"1992","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib54","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1530-0277.1996.tb05263.x","article-title":"Efficacy of buspirone in alcohol dependence: a review","volume":"20","author":"Malec","year":"1996","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib55","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1530-0277.1996.tb01644.x","article-title":"Efficacy of buspirone in alcohol dependence: a placebo-controlled trial","volume":"20","author":"Malec","year":"1996","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib56","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00023210-200418080-00002","article-title":"Pharmacotherapy of alcohol dependence: a review of the clinical data","volume":"18","author":"Mann","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2005.09.028_bib57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/01.ALC.0000108656.81563.05","article-title":"The efficacy of acamprosate in maintaining abstinence in alcohol-dependent individuals: results of a meta-analysis","volume":"28","author":"Mann","year":"2004","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib58","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1530-0277.1994.tb00098.x","article-title":"A double-blind placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence","volume":"18","author":"Mason","year":"1994","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib59","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archpsyc.56.8.719","article-title":"A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence","volume":"56","author":"Mason","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib60","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0893-133X(99)00147-5","article-title":"Naltrexone alters subjective responses to alcohol in heavy drinking subjects","volume":"22","author":"McCaul","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2005.09.028_bib61","first-page":"1386","article-title":"Naltrexone's effect on cue-elicited craving among alcoholics in treatment","volume":"23","author":"Monti","year":"1999","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib62","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1530-0277.2001.tb02170.x","article-title":"Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes","volume":"25","author":"Monti","year":"2001","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib64","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1530-0277.1997.tb03733.x","article-title":"A double-blind placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence","volume":"21","author":"Mueller","year":"1997","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib65","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/alcalc\/agg038","article-title":"Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study","volume":"38","author":"Namkoong","year":"2003","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.ejphar.2005.09.028_bib66","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1360-0443.1995.tb01013.x","article-title":"Effects of citalopram and a brief psychosocial intervention on alcohol intake, dependence and problems","volume":"90","author":"Naranjo","year":"1995","journal-title":"Addiction"},{"key":"10.1016\/j.ejphar.2005.09.028_bib67","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","article-title":"Naltrexone and coping skills therapy for alcohol dependence: a controlled study","volume":"49","author":"O'Malley","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib68","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archpsyc.1996.01830030039007","article-title":"Six-month follow-up of naltrexone and psychotherapy for alcohol dependence","volume":"53","author":"O\u2019Malley","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib70","first-page":"239","article-title":"Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol","volume":"30","author":"Paille","year":"1995","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.ejphar.2005.09.028_bib71","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1192\/bjp.171.1.73","article-title":"Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients","volume":"170","author":"Pelc","year":"1997","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib72","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2165\/00003495-199447060-00009","article-title":"Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome","volume":"47","author":"Peters","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2005.09.028_bib73","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.biopsych.2005.02.016","article-title":"Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders","volume":"57","author":"Petrakis","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib74","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00004714-200104000-00005","article-title":"Double-blind clinical trial of sertraline treatment for alcohol dependence","volume":"21","author":"Pettinati","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2005.09.028_bib75","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0028-3908(01)00008-9","article-title":"The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801","volume":"40","author":"Rammes","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2005.09.028_bib76","first-page":"65","article-title":"Does acamprosate diminish the appetite for alcohol in weaned alcoholics","volume":"51","author":"Rousseaux","year":"1996","journal-title":"J. Pharm. Belg."},{"key":"10.1016\/j.ejphar.2005.09.028_bib77","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0006-3223(97)00509-X","article-title":"Placebo-controlled study of sertraline in depressed recently abstinent alcoholics","volume":"44","author":"Roy","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib78","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/alcalc\/36.5.419","article-title":"Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment","volume":"36","author":"Rubio","year":"2001","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.ejphar.2005.09.028_bib79","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archpsyc.1996.01830080023006","article-title":"Relapse prevention by acamprosate: results from a placebo controlled study in alcohol dependence","volume":"53","author":"Sass","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib80","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0278-5846(01)00214-7","article-title":"Lisuride, a dopamine D2 receptor agonist, and anticraving drug expectancy as modifiers of relapse in alcohol dependence","volume":"26","author":"Schmidt","year":"2002","journal-title":"Prog. Neuro-psychopharmacol Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib81","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0165-6147(92)90026-3","article-title":"5-HT and alcohol abuse","volume":"13","author":"Sellers","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2005.09.028_bib82","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1530-0277.1994.tb00054.x","article-title":"Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence","volume":"18","author":"Sellers","year":"1995","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib83","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1192\/bjp.150.2.164","article-title":"Tiapride in the long-term management of alcoholics of anxious or depressive temperament","volume":"150","author":"Shaw","year":"1987","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib84","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1192\/bjp.165.4.515","article-title":"Tiapride in the prevention of relapse in recently detoxified alcoholics","volume":"165","author":"Shaw","year":"1994","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib85","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/alcalc\/36.1.2","article-title":"Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism","volume":"36","author":"Sinclair","year":"2001","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.ejphar.2005.09.028_bib86","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0166-4328(00)00203-5","article-title":"Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol","volume":"113","author":"S\u00f6derpalm","year":"2000","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib87","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1017\/S0140525X00022871","article-title":"Reconciling the role of central serotonin neurons in human and animal behavior","volume":"9","author":"Soubri\u00e9","year":"1986","journal-title":"Behav. Brain Sci."},{"key":"10.1016\/j.ejphar.2005.09.028_bib88","series-title":"Drugs for Relapse Prevention of Alcoholism","year":"2005"},{"key":"10.1016\/j.ejphar.2005.09.028_bib89","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0165-6147(97)89800-8","article-title":"Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes","volume":"18","author":"Spanagel","year":"1997","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2005.09.028_bib90","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1017\/S1461145704004997","article-title":"Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials","volume":"8","author":"Srisurapanont","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2005.09.028_bib101","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2007-979538","article-title":"Citalopram in the treatment of alcoholism: a double-blind placebo-controlled study","volume":"29","author":"Tiihonen","year":"1996","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib93","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004714-199202000-00004","article-title":"Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone)","volume":"12","author":"Tollefson","year":"1992","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2005.09.028_bib94","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","article-title":"Naltrexone in the treatment of alcohol dependence","volume":"49","author":"Volpicelli","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib95","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archpsyc.1997.01830200071010","article-title":"Naltrexone and alcohol dependence. Role of subject compliance","volume":"54","author":"Volpicelli","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2005.09.028_bib96","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0140-6736(96)91682-7","article-title":"Comparison of acamprosate and placebo in long-term treatment of alcohol dependence","volume":"347","author":"Whitworth","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2005.09.028_bib97","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1530-0277.1999.tb04105.x","article-title":"Ritanserin in relapse prevention in abstinent alcoholics: results from a placebo-controlled, double-blind international multicenter trial. Ritanserin in Alcoholism Work Group","volume":"23","author":"Wiesbeck","year":"1999","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2005.09.028_bib98","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/alcalc\/36.4.329","article-title":"Flupenthixol decanoate and relapse prevention in alcoholics: results from a placebo-controlled trial","volume":"36","author":"Wiesbeck","year":"2001","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.ejphar.2005.09.028_bib99","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-2999(93)90682-8","article-title":"Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors","volume":"231","author":"Zeise","year":"1993","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905009763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905009763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T09:14:52Z","timestamp":1736068492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299905009763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":92,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0014299905009763"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2005.09.028","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}